We are live on ! Find out more
CAS

CTC Alternative Strategies Portfolio holdings

AUM $44M
1-Year Est. Return 43.15%
This Fund
S&P 500
This Quarter Est. Return
-2.14%
1 Year Est. Return
+43.15%
3 Year Est. Return
+76.07%
5 Year Est. Return
10 Year Est. Return
AUM
$236M
AUM Growth
+$75.3M
Cap. Flow
+$76.1M
Cap. Flow %
32.27%
Top 10 Hldgs %
42.03%
Holding
297
New
168
Increased
7
Reduced
5
Closed
117

Sector Composition

Rank Sector Weight
1 Industrials 14%
2 Healthcare 12.15%
3 Financials 12.09%
4 Technology 9.03%
5 Consumer Discretionary 5.32%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
LICY
176
DELISTED
Li-Cycle Holdings Corp.
LICY
$86.2K 0.04%
+13,200
New +$72.9K
CMAX
177
DELISTED
CareMax, Inc. Class A Common Stock
CMAX
$59.4K 0.03%
+21,300
New +$66.5K
DNA icon
178
Ginkgo Bioworks
DNA
$555M
$56.6K 0.02%
+4,232
New +$126K
MNKD icon
179
MannKind Corp
MNKD
$1.25B
$56.6K 0.02%
+10,840
New +$49.2K
KLXE icon
180
KLX Energy Services
KLXE
$44.2M
$53.5K 0.02%
+10,800
New +$64.9K
AAL icon
181
American Airlines Group
AAL
$10.6B
-10,909
Closed -$167K
ABOS icon
182
Acumen Pharmaceuticals
ABOS
$165M
-11,100
Closed -$45K
ABSI icon
183
Absci
ABSI
$1.41B
-19,800
Closed -$112K
AKBA icon
184
Akebia Therapeutics
AKBA
$264M
-58,700
Closed -$107K
ALTO icon
185
Alto Ingredients
ALTO
$350M
-20,700
Closed -$45.1K
AMP icon
186
Ameriprise Financial
AMP
$49.5B
-3,330
Closed -$1.46M
AMTX icon
187
Aemetis
AMTX
$115M
-10,500
Closed -$62.9K
APLT
188
DELISTED
Applied Therapeutics
APLT
-10,400
Closed -$70.7K
AQST icon
189
Aquestive Therapeutics
AQST
$492M
-17,000
Closed -$72.4K
ARHS icon
190
Arhaus
ARHS
$1.37B
-18,600
Closed -$286K
ATOS icon
191
Atossa Therapeutics
ATOS
$24.1M
-2,420
Closed -$65.3K
AUB icon
192
Atlantic Union Bankshares
AUB
$6.02B
-11,200
Closed -$395K
AXTI icon
193
AXT Inc
AXTI
$4.92B
-12,300
Closed -$56.5K
BDTX icon
194
Black Diamond Therapeutics
BDTX
$110M
-11,000
Closed -$55.8K
BLND icon
195
Blend Labs
BLND
$472M
-42,300
Closed -$137K
BR icon
196
Broadridge
BR
$18.8B
-1,098
Closed -$225K
BROS icon
197
Dutch Bros
BROS
$9.32B
-12,300
Closed -$406K
BUR icon
198
Burford Capital
BUR
$942M
-16,700
Closed -$267K
CATX icon
199
Perspective Therapeutics
CATX
$339M
-6,990
Closed -$83.2K
CIM
200
Chimera Investment
CIM
$993M
-3,767
Closed -$52.1K

Similar funds

CTC Alternative Strategies's Q2 2024 Portfolio in Review

As of Q2 2024, CTC Alternative Strategies held 297 positions worth $236M, up 47% from $160M the previous quarter. Its ten largest holdings account for 42% of the portfolio.

CTC Alternative Strategies deployed $76.1M of net new capital in Q2 2024, opening 168 new positions and adding to 7 existing holdings. Its largest new stake was iShares 20+ Year Treasury Bond ETF: 90,000 shares worth $8.26M.

By sector, the portfolio is most concentrated in Industrials at 14% of assets, up from 4.2% a quarter earlier, followed by Healthcare and Financials.

On the sell side, the largest reduction was Kimberly-Clark, an estimated $1.32M trimmed.

  • CTC Alternative Strategies's largest Q2 2024 buy was iShares 20+ Year Treasury Bond ETF: 90,000 shares worth $8.26M.
  • CTC Alternative Strategies added most to iShares iBoxx $ Investment Grade Corporate Bond ETF in Q2 2024, an estimated $26.7M increase.
  • CTC Alternative Strategies's biggest Q2 2024 reduction was Kimberly-Clark, cutting an estimated $1.32M.
  • CTC Alternative Strategies fully exited iShares Bitcoin Trust in Q2 2024, selling an estimated $27.7M.
  • CTC Alternative Strategies's ten largest holdings make up 42% of its $236M portfolio in Q2 2024.
  • CTC Alternative Strategies opened 168 new positions and closed 117 in Q2 2024.
  • CTC Alternative Strategies's portfolio value rose 47% quarter-over-quarter to $236M.

Based on CTC Alternative Strategies's 13F filing for Q2 2024, filed 2 Aug 2024.